CSBR
Champions Oncology Inc
NASDAQ: CSBR · HEALTHCARE · BIOTECHNOLOGY
$4.92
+1.86% today
Updated 2026-10-28
Market cap
$66.95M
P/E ratio
—
P/S ratio
1.10x
EPS (TTM)
$-0.07
Dividend yield
—
52W range
$5 – $8
Volume
0.0M
Champions Oncology Inc (CSBR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$4.92
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$10.38
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -1.87%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.